A 1-year Comparison of Generic Tacrolimus (Tacni) and Prograf in Renal Transplant Patients - a Retrospective Matched Pair Analysis, GenTac

Vastra Gotaland Region

Status

Completed

Conditions

Renal Transplantation

Treatments

Drug: Prograf

Drug: Generic tacrolimus

Study type

Observational

Funder types

Other

Identifiers

NCT02587052

2015-08-01

Details and patient eligibility

About

This is a retrospective analysis of two different cohorts of patients that has undergone renal transplantation. This is a matched pair analysis of 100 patients treated with generic tacrolimus that will be compared with 100 matched controls treated with Prograf. Data will be obtained from patients' charts, from the Swedish National Kidney Registry and from a local registry at Transplantationscentrum. Patients included in the study are patients receiving a first single kidney transplant from a deceased or a living donor, treated with Prograf or Tacni and transplanted between transplanted January 2012 and August 2014. The 1-year-outcome of patients following renal transplantation, including BPAR, serious adverse effects and graft survival will be analysed.

Enrollment

186 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients receiving a first single kidney transplant from a deceased or a living donor.
Patients treated with Prograf or or generic tacrolimus
Patients transplanted between 1 October 2012 and 1 August 2014

Exclusion criteria